Quetmolimab: A Deep Dive into KANAb 001 and E-6011 Quetmo compound, E-6011, is a promising treatment targeting PD-1. First study results from both programs, KANAb 001 and E-6011, suggest positive effects in various https://www.targetmol.com/compound/quetmolimab